Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.36 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16253612 | 0.90 | PTGS2 (0.38) | PTGS2TUBB1 | |
| SCHEMBL16253656 | 0.87 | PTGS2 (0.38) | PTGS2TUBB1 | |
| SCHEMBL18465078 | 0.83 | PTGS2 (0.42) | PTGS2HSPA5DHFRTUBB1ALDH1A1 | |
| SCHEMBL16253653 | 0.80 | PTGS2 (0.42) | PTGS2DHFRTUBB1ALDH1A1 | |
| SCHEMBL15002584 | 0.80 | ALDH1A1 (0.36) | PTGS2HSPA5ALDH1A1TSHRTDP1 | |
| SCHEMBL16253655 | 0.80 | PTGS2 (0.42) | PTGS2DHFRTUBB1 | |
| SCHEMBL17761938 | 0.80 | PTGS2 (0.42) | PTGS2TUBB1 | |
| SCHEMBL14999413 | 0.80 | RARG (0.37) | PTGS2ALDH1A1TSHRTDP1 | |
| SCHEMBL16253657 | 0.80 | PTGS2 (0.37) | PTGS2TUBB1 | |
| SCHEMBL18634394 | 0.79 | PTGS2 (0.41) | PTGS2HSPA5DHFRTUBB1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170080409-A1 | CATALYSTS FOR EPOXIDE CARBONYLATION | NOVOMER, INC. (US) | 2017-03-23 | — | — | US | disclosed |
| US-9359474-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-20150368394-A1 | CATALYSTS AND METHODS FOR POLYESTER PRODUCTION | NOVOMER, INC. | 2015-12-24 | — | — | US | disclosed |
| US-8956989-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-20140343246-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2014-11-20 | — | — | US | disclosed |
| US-8633123-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2014-01-21 | — | — | US | disclosed |
| US-20130144033-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2013-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130144033-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | PTGS2 130/4885HSPA5 3232/4885DHFR 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.